Blood glucose monitoring- an overview of current and future non-invasive devices.


Journal

Diabetes & metabolic syndrome
ISSN: 1878-0334
Titre abrégé: Diabetes Metab Syndr
Pays: Netherlands
ID NLM: 101462250

Informations de publication

Date de publication:
Historique:
received: 17 12 2019
revised: 05 05 2020
accepted: 06 05 2020
pubmed: 5 6 2020
medline: 10 7 2021
entrez: 5 6 2020
Statut: ppublish

Résumé

Blood glucose monitoring is very important for individuals with diabetes due to its rate determining role in medication strength adjustment and observation of possible life-threatening hypoglycemia. Possible non-invasive devices can overcome some of these burdens and could increase adherence towards checking blood glucose. Data extraction methods were primarily based through various PubMed scholarly articles for real-world examples of non-invasive approaches. Additional articles were used in adjust as supplementary to the PubMed articles. Non-invasive technology is being heavily researched and could create a new market that could offer novel options for blood glucose monitoring at home. The lack of adherence for blood glucose monitoring may be tied to current blood glucose monitoring devices, which require invasive procedures that are often painful and expensive to acquire. Certain non-invasive devices have and are being developed for accurately assessing the blood glucose levels of individuals when compared to current blood glucose monitoring devices. Blood glucose monitoring is very important for the health and safety of individuals with diabetes. It is important to consider the direct problems that may occur from the lack of adherence to blood glucose monitoring and propose options to help reduce the issues associated with current devices. Different non-invasive technologies can tailor to the needs of patients with diabetes based on the body target that is used for detection. Further research may be needed to help improve the specificity and sensitivity of certain technologies.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Blood glucose monitoring is very important for individuals with diabetes due to its rate determining role in medication strength adjustment and observation of possible life-threatening hypoglycemia. Possible non-invasive devices can overcome some of these burdens and could increase adherence towards checking blood glucose.
METHODS METHODS
Data extraction methods were primarily based through various PubMed scholarly articles for real-world examples of non-invasive approaches. Additional articles were used in adjust as supplementary to the PubMed articles.
RESULTS RESULTS
Non-invasive technology is being heavily researched and could create a new market that could offer novel options for blood glucose monitoring at home. The lack of adherence for blood glucose monitoring may be tied to current blood glucose monitoring devices, which require invasive procedures that are often painful and expensive to acquire. Certain non-invasive devices have and are being developed for accurately assessing the blood glucose levels of individuals when compared to current blood glucose monitoring devices.
CONCLUSION CONCLUSIONS
Blood glucose monitoring is very important for the health and safety of individuals with diabetes. It is important to consider the direct problems that may occur from the lack of adherence to blood glucose monitoring and propose options to help reduce the issues associated with current devices. Different non-invasive technologies can tailor to the needs of patients with diabetes based on the body target that is used for detection. Further research may be needed to help improve the specificity and sensitivity of certain technologies.

Identifiants

pubmed: 32497964
pii: S1871-4021(20)30135-1
doi: 10.1016/j.dsx.2020.05.016
pii:
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

739-751

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of competing interest The author is involved with Breath Health Inc. (GLUCAIRTM) however we made sure that there was no bias in the break-down of the various non-invasive discussed. In fact, upon completion, it is clear that much more was discussed regarding the other areas.

Auteurs

Anmole S Bolla (AS)

Massachusetts College of Pharmacy and Health Sciences University, Boston, MA, USA.

Ronny Priefer (R)

Massachusetts College of Pharmacy and Health Sciences University, Boston, MA, USA. Electronic address: ronny.priefer@mcphs.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH